ICLR — ICON

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and m...

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Industry

诊断与研究

Sector

Healthcare

Exchange

NASD

First trade date

1998-05-15

The interactive platform loads with JavaScript. Research tools are for informational purposes.